Bioline Rx logo

Bioline Rx Share Price Today

(NASDAQ: BLRX)

Bioline Rx share price is $3.21 & ₹279.17 as on 6 Mar 2025, 2.30 'hrs' IST

$3.21

0.14

(4.56%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Bioline Rx share price in Dollar and Rupees. Guide to invest in Bioline Rx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bioline Rx, along with analyst recommendations, forecasts, and comprehensive financials.

Bioline Rx share price movements

  • Today's Low: $3.07
    Today's High: $3.29

    Day's Volatility :6.55%

  • 52 Weeks Low: $3.05
    52 Weeks High: $56.00

    52 Weeks Volatility :94.55%

Bioline Rx (BLRX) Returns

PeriodBioline Rx LtdIndex (Russel 2000)
3 Months
-69.78%
0.0%
6 Months
-87.52%
0.0%
1 Year
-93.96%
0.0%
3 Years
-94.78%
-11.6%

Bioline Rx (BLRX) Key Statistics

in dollars & INR

Previous Close
$3.07
Open
$3.1367
Today's High
$3.29
Today's Low
$3.0744
Market Capitalization
$11.2M
Today's Volume
$4.1K
52 Week High
$56.0
52 Week Low
$3.0541
Revenue TTM
$22.0M
EBITDA
$-25.5M
Earnings Per Share (EPS)
$-12.0
Profit Margin
-90.57%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-184.09%

How to invest in Bioline Rx Stock (BLRX) from India?

It is very easy for Indian residents to invest directly in Bioline Rx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioline Rx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioline Rx or BLRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioline Rx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioline Rx shares which would translate to 0.271 fractional shares of Bioline Rx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bioline Rx, in just a few clicks!

Returns in Bioline Rx (BLRX) for Indian investors in Rupees

The Bioline Rx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioline Rx investment value today

Current value as on today

₹11,282

Returns

₹88,718

(-88.72%)

Returns from Bioline Rx Stock

₹93,681 (-93.68%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Bioline Rx (BLRX)

-90%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Bioline Rx Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bioline Rx

  • Values First Advisors Inc

    0.12%

  • Rhumbline Advisers

    0.03%

  • Gradient Investments

    0.03%

  • Watts Gwilliam and Company, LLC

    0.02%

  • CapTrust Financial Advisors

    0.01%

  • Weaver Consulting Group

    0.01%

Analyst Recommendation on Bioline Rx

Analyst Forecast on Bioline Rx Stock (BLRX)

What analysts predicted

Upside of 4884.42%

Target:

$160.00

Current:

$3.21

Insights on Bioline Rx Stock (Ticker Symbol: BLRX)

  • Price Movement

    In the last 3 months, BLRX stock has moved down by -69.8%
  • BLRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 156.5%
  • BLRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 142.7%
  • Price to Sales

    ForBLRX every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Bioline Rx Technicals Summary

Sell

Neutral

Buy

Bioline Rx is currently in a neutral trading position according to technical analysis indicators.

Bioline Rx (BLRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioline Rx Ltd logo
-9.44%
-87.52%
-93.96%
-94.78%
-95.46%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioline Rx Ltd logo
NA
NA
0.2
-3.2
-1.84
-0.33
NA
0.01
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioline Rx Ltd logo
NA
$11.2M
-95.46%
NA
-90.57%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Bioline Rx

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Organization
Bioline Rx
Employees
79
CEO
Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA
Industry
Health Technology

Management People of Bioline Rx

NameTitle
Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA
Chief Executive Officer
Ms. Mali Zeevi CPA, CPA
Chief Financial Officer
Dr. Ella Sorani Ph.D.
Chief Development Officer
Mr. John Lacey
Head of Corporate Communications & Investor Relations
Ms. Tsipi Keren-Lehrer B.Sc., L.L.B.
Head of BD & Strategic Advisor
Mr. Raziel Fried
Treasurer & Budgetary Control Director

Important FAQs about investing in BLRX Stock from India :

What is Bioline Rx share price today?

Bioline Rx share price today stands at $3.21, Open: $3.14 ; Previous Close: $3.07 ; High: $3.29 ; Low: $3.07 ; 52 Week High: $56.00 ; 52 Week Low: $3.05.

The stock opens at $3.14, after a previous close of $3.07. The stock reached a daily high of $3.29 and a low of $3.07, with a 52-week high of $56.00 and a 52-week low of $3.05.

Can Indians buy Bioline Rx shares?

Yes, Indians can invest in the Bioline Rx (BLRX) from India.

With INDmoney, you can buy Bioline Rx at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioline Rx at zero transaction cost.

How can I buy Bioline Rx shares from India?

It is very easy to buy Bioline Rx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioline Rx (BLRX) be purchased?

Yes, you can buy fractional shares of Bioline Rx with INDmoney app.

What are the documents required to start investing in Bioline Rx stocks?

To start investing in Bioline Rx, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioline Rx Stock (BLRX)?

Today’s highest price of Bioline Rx (BLRX) is $3.29.

Today’s lowest price of Bioline Rx (BLRX) is $3.07.

What is today's market capitalisation of Bioline Rx?

Today's market capitalisation of Bioline Rx BLRX is 11.2M

What is the 52 Week High and Low Range of Bioline Rx Stock (BLRX)?

  • 52 Week High

    $56.00

  • 52 Week Low

    $3.05

What are the historical returns of Bioline Rx (BLRX)?

  • 1 Month Returns

    -9.44%

  • 3 Months Returns

    -87.52%

  • 1 Year Returns

    -93.96%

  • 5 Years Returns

    -95.46%

Who is the Chief Executive Officer (CEO) of Bioline Rx ?

Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA is the current Chief Executive Officer (CEO) of Bioline Rx.